DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off
Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s
President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel
NCI Clarifies Plan For Review Of Epidemiologic Research
Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial
Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers
Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment
Emerging Technologies: Company To Expand Program Studying Polymer Platinates
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”
